Supplementary Material from Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations

Authors:
  • ZZZachary S. Zumsteg
    Zachary S. Zumsteg
  • NMNatasha Morse
    Natasha Morse
  • GKGabriel Krigsfeld
    Gabriel Krigsfeld
  • GGGaorav Gupta
    Gaorav Gupta
  • DHDaniel S. Higginson
    Daniel S. Higginson
  • NLNancy Y. Lee
    Nancy Y. Lee
  • LMLuc Morris
    Luc Morris
  • IGIan Ganly
    Ian Ganly
  • SSStephan L. Shiao
    Stephan L. Shiao
  • SPSimon N. Powell
    Simon N. Powell
  • CCChristine H. Chung
    Christine H. Chung
  • MSMaurizio Scaltriti
    Maurizio Scaltriti

Abstract
No abstract available